Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MEMANT-3310 by Antabio for Acinetobacter Infections: Likelihood of Approval
MEMANT-3310 is under clinical development by Antabio and currently in Phase I for Acinetobacter Infections. According to GlobalData, Phase I...
MEMANT-3310 by Antabio for Enterobacteriaceae Infections: Likelihood of Approval
MEMANT-3310 is under clinical development by Antabio and currently in Phase I for Enterobacteriaceae Infections. According to GlobalData, Phase I...
MEMANT-3310 by Antabio for Acinetobacter Infections: Likelihood of Approval
MEMANT-3310 is under clinical development by Antabio and currently in Phase I for Acinetobacter Infections. According to GlobalData, Phase I...
MEMANT-3310 by Antabio for Enterobacteriaceae Infections: Likelihood of Approval
MEMANT-3310 is under clinical development by Antabio and currently in Phase I for Enterobacteriaceae Infections. According to GlobalData, Phase I...